Management reiterated expectations for FDA approval of LNZ100 by August 2025, with a commercial launch in Q4 2025. Manufacturing activities are aligned to support this timeline, with bulk production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback